Cullinan Therapeutics, Inc.

CGEM · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$103,335$72,820$76,655$83,005
Short-Term Investments$229,261$192,662$227,172$315,972
Receivables$0$0$0$3,000
Inventory$0$0$0$0
Other Curr. Assets$9,639$10,429$13,945$12,691
Total Curr. Assets$342,235$275,911$317,772$414,668
Property Plant & Equip (Net)$1,535$1,749$2,157$2,350
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$139,995$242,302$259,386$204,440
Tax Assets$0$0$0$0
Other NC Assets$361$367$366$366
Total NC Assets$141,891$244,418$261,909$207,156
Other Assets$0$0$0$0
Total Assets$484,126$520,329$579,681$621,824
Liabilities
Payables$1,722$2,461$3,401$1,682
Short-Term Debt$1,188$1,394$1,347$1,302
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$29,847$24,203$22,601$27,663
Total Curr. Liab.$32,757$28,058$27,349$30,647
LT Debt$0$125$493$849
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$125$493$849
Other Liabilities$0$0$0$0
Cap. Leases$1,188$1,519$1,840$2,151
Total Liabilities$32,757$28,183$27,842$31,496
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$6$6
Retained Earnings-$537,406-$486,796-$416,741-$368,240
AOCI$973$607$505-$133
Other Equity$987,796$978,329$968,069$958,695
Total Equity$451,369$492,146$551,839$590,328
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$484,126$520,329$579,681$621,824
Net Debt-$102,147-$71,301-$74,815-$80,854
Cullinan Therapeutics, Inc. (CGEM) Financial Statements & Key Stats | AlphaPilot